Revenue: The sum of all revenue fields included for a company's operating activities.
AC Immune (ACIU) Revenue data is not available for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-5.62M |
|
-- |
|
-- |
|
$20.76M |
|
$-20.76M |
|
$-1.34M |
|
$-5.62M |
|
$-5.62M |
|
$-5.63M |
|
$-5.63M |
|
$-5.62M |
|
$-5.63M |
|
$-4.28M |
|
$-20.17M |
|
84.69M |
|
84.69M |
|
$-0.06 |
|
$-0.06 |
|
| Balance Sheet Financials | |
$139.41M |
|
$3.76M |
|
$64.23M |
|
$203.64M |
|
$15.12M |
|
-- |
|
$9.57M |
|
$24.70M |
|
$178.94M |
|
$122.78M |
|
$178.94M |
|
99.20M |
|
| Cash Flow Statement Financials | |
$-67.29M |
|
$73.12M |
|
$48.18M |
|
$35.18M |
|
$87.43M |
|
$52.25M |
|
$4.86M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-68.18M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-3.14% |
|
-4.58% |
|
-2.76% |
|
-3.14% |
|
$1.80 |
|
$-0.81 |
|
$-0.79 |
|